Cassava Sciences appoints R. Christopher Cook as SVP and General Counsel, effective Dec 1, 2022

FILANA THERAPEUTICS, INC.

Cook will receive annual base salary of $425,000 and option to purchase 100,000 shares vesting over 48 months.
He joins from Alcon Inc., where he was Global Head of Litigation and Government Investigations since 2017.
Previously a litigation partner at Jones Day and an Assistant U.S. Attorney in Chicago.
This is a newly created position reporting to President & CEO Remi Barbier.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

R. Christopher Cook

Senior Vice President and General Counsel

FLNA · FILANA THERAPEUTICS, INC.

Effective: 2022-12-01
Filed: October 27, 2022, 7:59 PM ET

On October 27, 2022, Cassava Sciences, Inc. (the “Company”) announced the appointment of R. Christopher Cook, age 58, as Senior Vice President and General Counsel, effective on or before December 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

R. Christopher Cook was appointed as Senior Vice President and General Counsel at FILANA THERAPEUTICS, INC..

Action: appointed
Role: Senior Vice President and General Counsel

Exact text from the filing

On October 27, 2022, Cassava Sciences, Inc. (the “Company”) announced the appointment of R. Christopher Cook, age 58, as Senior Vice President and General Counsel, effective on or before December 1, 2022.

View on SEC.gov

FILANA THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001069530-22-000051

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.